| RS150351852 |
COG5
|
Health Risk |
Conflicting classifications of pathogenicity |
COG5-congenital disorder of glycosylation, COG5-congenital disorder of glycosylation |
| RS150352833 |
PCCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Propionic acidemia, PCCA-related disorder |
| RS150352976 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 2 |
| RS150354113 |
DCHS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, DCHS1-related disorder |
| RS150355046 |
TNFAIP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autoinflammatory syndrome, familial |
| RS150355232 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Malignant tumor of breast |
| RS150355335 |
CCBE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hennekam lymphangiectasia-lymphedema syndrome 1, Hennekam lymphangiectasia-lymphedema syndrome 1 |
| RS150355356 |
PCNT
|
Health Risk |
Conflicting classifications of pathogenicity |
PCNT-related disorder, Inborn genetic diseases |
| RS150355624 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS150356488 |
CAPN3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2A, CAPN3-related disorder |
| RS150356636 |
EVI2B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS150357258 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS150358276 |
PCDH12
|
Health Risk |
Conflicting classifications of pathogenicity |
Diencephalic-mesencephalic junction dysplasia syndrome 1, Inborn genetic diseases |
| RS150358307 |
CUBN
|
Health Risk |
Conflicting classifications of pathogenicity |
Imerslund-Grasbeck syndrome, Proteinuria |
| RS150359172 |
DNMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary sensory neuropathy-deafness-dementia syndrome, DNMT1-related disorder |
| RS150363441 |
CLN6
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis, Ceroid lipofuscinosis |
| RS150364458 |
GLIS3
|
Health Risk |
Conflicting classifications of pathogenicity |
Neonatal diabetes mellitus with congenital hypothyroidism, GLIS3-related disorder |
| RS150365980 |
CDC73
|
Health Risk |
Conflicting classifications of pathogenicity |
Parathyroid carcinoma, Hyperparathyroidism 2 with jaw tumors |
| RS150367317 |
EVC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Curry-Hall syndrome, Ellis-van Creveld syndrome |
| RS150368249 |
CAV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pulmonary hypertension, primary |
| RS150368544 |
DCTN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 1, Perry syndrome |
| RS150368802 |
ZNF408
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS150368988 |
WFS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Monogenic diabetes, Autosomal dominant nonsyndromic hearing loss 6 |
| RS150369301 |
MAP2K2
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome, RASopathy |
| RS150370217 |
ARHGEF18
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS150370442 |
AFG2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome, Inborn genetic diseases |
| RS150370598 |
TYRP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Oculocutaneous albinism type 3, Oculocutaneous albinism type 3 |
| RS150370762 |
CHIT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Chitotriosidase deficiency, Chitotriosidase deficiency |
| RS150371881 |
ABRAXAS1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS150372520 |
ARHGEF10
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS150372864 |
FLAD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cholangiocarcinoma, Ovarian serous cystadenocarcinoma |
| RS150372878 |
RELN
|
Health Risk |
Conflicting classifications of pathogenicity |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS150373546 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS150373788 |
IFT43
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS150373930 |
EVC
|
Health Risk |
Conflicting classifications of pathogenicity |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS150374940 |
TNFRSF13C
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency, common variable |
| RS150375708 |
TRRAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS150376179 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, COL6A3-related disorder |
| RS150376433 |
DOK7
|
Health Risk |
Likely pathogenic |
Fetal akinesia deformation sequence 3, Fetal akinesia deformation sequence 3 |
| RS150376474 |
MMAA
|
Health Risk |
Pathogenic/Likely pathogenic |
Methylmalonic aciduria, cblA type |
| RS150376603 |
VPS13B
|
Health Risk |
Conflicting classifications of pathogenicity |
Cohen syndrome, Cohen syndrome |
| RS150376715 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS150377265 |
F11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary factor XI deficiency disease, Plasma factor XI deficiency |
| RS150377792 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS150378280 |
MYLK
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 7 |
| RS150378634 |
SLC12A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypokalemia-hypomagnesemia, Familial hypokalemia-hypomagnesemia |
| RS150378645 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Collagen 6-related myopathy, Bethlem myopathy 1A |
| RS150379164 |
LPIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Majeed syndrome, Majeed syndrome |
| RS150379789 |
SLC24A5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS150380359 |
LMOD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 10, Inborn genetic diseases |
| RS150381599 |
PRPH2
|
Health Risk |
Conflicting classifications of pathogenicity |
PRPH2-related disorder, PRPH2-related disorder |
| RS150382307 |
SIM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Monogenic diabetes, Inborn genetic diseases |
| RS150382575 |
GYS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disorder due to hepatic glycogen synthase deficiency, Glycogen storage disorder due to hepatic glycogen synthase deficiency |
| RS150382715 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Donnai-Barrow syndrome, Inborn genetic diseases |
| RS150383726 |
IL17RC
|
Health Risk |
Conflicting classifications of pathogenicity |
Candidiasis, familial |
| RS150384171 |
CD320
|
Health Risk |
Conflicting classifications of pathogenicity; other |
Methylmalonic acidemia due to transcobalamin receptor defect, CD320-related disorder |
| RS150385253 |
SLC44A4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS150385329 |
IKZF1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS150385364 |
PNPLA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Neutral lipid storage myopathy, Neutral lipid storage myopathy |
| RS150385900 |
VCL
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Dilated cardiomyopathy 1W |
| RS150387338 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS150387982 |
IFT27
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, IFT27-related disorder |
| RS150388984 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease, adult type |
| RS150389057 |
CYP27A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cholestanol storage disease, Cardiovascular phenotype |
| RS150390726 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS150391376 |
GMNN
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS150391806 |
TRPM4
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial heart block type IB, Cardiovascular phenotype |
| RS150391936 |
RFT1
|
Health Risk |
Conflicting classifications of pathogenicity |
RFT1-congenital disorder of glycosylation, RFT1-congenital disorder of glycosylation |
| RS150393340 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Inborn genetic diseases |
| RS150393409 |
FAN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Karyomegalic interstitial nephritis, Karyomegalic interstitial nephritis |
| RS150393424 |
NPR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Acromesomelic dysplasia 1, Maroteaux type |
| RS150393677 |
MPDZ
|
Health Risk |
Conflicting classifications of pathogenicity |
MPDZ-related disorder, Hydrocephalus |
| RS150393722 |
ANKRD11
|
Health Risk |
Conflicting classifications of pathogenicity |
KBG syndrome, KBG syndrome |
| RS150394215 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMA2-related muscular dystrophy, Congenital muscular dystrophy due to partial LAMA2 deficiency |
| RS150395094 |
BBS4
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, BBS4-related disorder |
| RS150395163 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Donnai-Barrow syndrome, LRP2-related disorder |
| RS150395210 |
KCNT1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 14 |
| RS150395515 |
VCAN
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, VCAN-related disorder |
| RS150395645 |
SGCB
|
Health Risk |
Conflicting classifications of pathogenicity |
Qualitative or quantitative defects of beta-sarcoglycan, Autosomal recessive limb-girdle muscular dystrophy type 2E |
| RS150396172 |
NLRP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cryopyrin associated periodic syndrome, Familial amyloid nephropathy with urticaria AND deafness |
| RS150397427 |
TMPRSS3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 8, Autosomal recessive nonsyndromic hearing loss 8 |
| RS150397493 |
MYO1E
|
Health Risk |
Conflicting classifications of pathogenicity |
MYO1E-related disorder, Focal segmental glomerulosclerosis 6 |
| RS150399981 |
COL27A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS150401168 |
COL5A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, arthrochalasia type |
| RS150401343 |
KCND3
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome 9, Spinocerebellar ataxia type 19/22 |
| RS150401753 |
USP26
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS150402866 |
SALL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Duane-radial ray syndrome, SALL4-related disorder |
| RS150402972 |
AARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS150402974 |
TUB
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy and obesity, TUB-related disorder |
| RS150403702 |
MYO15A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 3, Inborn genetic diseases |
| RS150404125 |
ELN
|
Health Risk |
Conflicting classifications of pathogenicity |
Supravalvar aortic stenosis, Cutis laxa |
| RS150404840 |
SAMD9L
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, SAMD9L-related disorder |
| RS150405747 |
FN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Glomerulopathy with fibronectin deposits 2, Spondylometaphyseal dysplasia - Sutcliffe type |
| RS150407012 |
TNFRSF4
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined immunodeficiency due to OX40 deficiency, Combined immunodeficiency due to OX40 deficiency |
| RS150407952 |
WHRN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 31, Usher syndrome type 2D |
| RS150408179 |
ATP6V0A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cutis laxa with osteodystrophy, Cutis laxa with osteodystrophy |
| RS150408832 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS150409035 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS150411351 |
MTRR
|
Health Risk |
Conflicting classifications of pathogenicity |
Methylcobalamin deficiency type cblE, Neural tube defects |
| RS150411706 |
KIF1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Neuroblastoma |